< 1 minute read
Sep. 18, 2021

"compound 4d"

oral selective PI3K_ kinase inhibitor <10 mg proj. human dose from virtual screening and opt. ACS Med. Chem. Lett., Nov. 19, 2020 Merck, Boston, CA

drughunter.com
Drug Hunter Team
Loading...

twitterlinkedinemail

Other molecules you may be interested in